"Smart Summon" feature leads to traffic accident, US regulatory agency to launch investigation into Tesla, Inc. (TSLA.US)
Electric car manufacturer Tesla (TSLA.US) is facing an investigation by the US transportation safety regulatory agency regarding issues related to its "Advanced Summon (AS)" feature.
Electric car manufacturer Tesla, Inc. (TSLA.US) is facing an investigation by the US traffic safety regulatory agency related to its "Advanced Summon (AS)" feature.
The investigation involves approximately 2.585 million Tesla, Inc. vehicles, including Model S and X from 2016 to 2025, Model 3 from 2017 to 2025, and Model Y equipped with full self-driving software from 2020 to 2025.
Summon and Advanced Summon are features on some Tesla, Inc. vehicles that allow users to remotely move the vehicle to themselves or another specified location using a mobile app.
The US National Highway Traffic Safety Administration (NHTSA) Office of Defects Investigation (ODI) has received one complaint alleging a collision caused by the Summon feature and is reviewing at least three similar media reports involving similar accidents.
All four accidents involved Tesla, Inc. vehicles running the Summon system failing to detect obstacles or parked vehicles, resulting in collisions.
ODI has initiated a preliminary evaluation to investigate the functionality of Advanced Summon as it relates to the subject and similar collisions, including the operation and on-site performance of the system in vehicles equipped with FSD (full self-driving) and vehicles provided for free trial use.
As early as October of last year, NHTSA launched another investigation on 2.4 million Tesla, Inc. vehicles with FSD software installed following four accident reports. In one such accident, a pedestrian was fatally struck by a Tesla, Inc. vehicle.
Related Articles

Cancer drug developer Revolution (RVMD.US) surged after hours! Rumored to be in talks with Merck & Co., Inc. (MRK.US) for acquisition, with the transaction price potentially reaching $32 billion.

HAITONG INT'L: Maintains "outperform" rating on MAO GEPING (01318) with a target price of 108.2 Hong Kong dollars.

Northeast: Ningbo Joyson Electronic Corp. (00699) given a "buy" rating, major breakthrough in smart driving business.
Cancer drug developer Revolution (RVMD.US) surged after hours! Rumored to be in talks with Merck & Co., Inc. (MRK.US) for acquisition, with the transaction price potentially reaching $32 billion.

HAITONG INT'L: Maintains "outperform" rating on MAO GEPING (01318) with a target price of 108.2 Hong Kong dollars.

Northeast: Ningbo Joyson Electronic Corp. (00699) given a "buy" rating, major breakthrough in smart driving business.

RECOMMEND

Bank Of America Sees Three Drivers Supporting Chinese Consumer Stocks: Low Base, Deep Undervaluation, And Convertible‑Like Defensive Traits
07/01/2026

Cross‑Border E‑Commerce In 2025: Tariffs, Trade Wars, And Shifting Away From The United States
07/01/2026

Asian Stock Markets Record The Strongest Annual Start Ever As Shanghai Composite Hits Multi‑Year High And Sets Longest Winning Streak; Japan And Korea Rally
07/01/2026


